Jefferies Group LLC Axsome Therapeutics, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $181,529 - $390,362	-8,350 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$23.7 - $41.39 $197,895 - $345,606	8,350 New	8,350 $345,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $197,895 - $345,606	8,350 New	8,350 $346,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $140,862 - $346,378	-3,419 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $57,131 - $363,234	3,419 New	3,419 $353,000
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $912,426 - $1.75 Million	-67,788 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $178,282 - $1.11 Million	67,788 New	67,788 $965,000

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.